BioNexus Gene Lab Corp SEC filings BGLC
BioNexus Gene Lab Corp has 157 filings in SEC EDGAR's recent list, going back to Jan 29, 2019. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 18, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 15, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | May 31, 2024 | Sep 30, 2023 |
| 10-Q/A | Amended quarterly report | May 31, 2024 | Jun 30, 2023 |
| 10-Q/A | Amended quarterly report | May 31, 2024 | Mar 31, 2023 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-Q/A | Amended quarterly report | Mar 26, 2024 | Sep 30, 2023 |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 16, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 18, 2021 | Mar 31, 2021 |
| 10-Q/A | Amended quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Nov 3, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BGLC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WY
- Headquarters
- Kuala Lumpur
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1737523
- Former names
- BioNexus Gene Lab Coporation (until May 8, 2020)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.